Literature DB >> 15109562

Small cell lung cancer: the importance of the extracellular matrix.

Robert C Buttery1, Robert C Rintoul, Tariq Sethi.   

Abstract

Lung cancer is the leading cause of cancer deaths in the UK and the small cell lung cancer (SCLC) phenotype is the most aggressive form of this disease, with a high metastatic potential and the development of resistance to chemotherapy. Evidence now suggests that these features may be due to important links between the cancer cells and proteins in their local extracellular matrix (ECM). This article reviews the evidence for a chemoprotective effect of extracellular matrix in small cell lung cancer and discusses the importance of integrin-mediated signalling pathways in this setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109562     DOI: 10.1016/S1357-2725(03)00261-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  18 in total

1.  Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.

Authors:  Jie Luo; Bin Chen; Xian-Xiu Ji; Song-Wen Zhou; Di Zheng
Journal:  Tumour Biol       Date:  2015-08-28

2.  Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts.

Authors:  Michael D Amatangelo; Daniel E Bassi; Andrés J P Klein-Szanto; Edna Cukierman
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Inhibition of the growth of non-small cell lung cancer by miRNA-1271.

Authors:  Zhen Zhou; Xiaoming Niu; Chuanjia Li; Shengping Sheng; Shun Lu
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel.

Authors:  Kan Chen; Wenjun Shi
Journal:  Tumour Biol       Date:  2016-02-08

5.  MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition.

Authors:  Liqun Zhang; Hongyu Quan; Sihai Wang; XueHui Li; Xiaoyu Che
Journal:  Tumour Biol       Date:  2015-05-17

6.  M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.

Authors:  T Chu; L Jiang; W Ying; B Han
Journal:  Clin Transl Oncol       Date:  2016-07-28       Impact factor: 3.405

7.  Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1.

Authors:  Gaoxiang Zhao; Liyan Gong; Dan Su; Yujuan Jin; Chenchen Guo; Meiting Yue; Shun Yao; Zhen Qin; Yi Ye; Ying Tang; Qibiao Wu; Jian Zhang; Binghai Cui; Qiurong Ding; Hsinyi Huang; Liang Hu; Yuting Chen; Peiyuan Zhang; Guohong Hu; Luonan Chen; Kwok-Kin Wong; Daming Gao; Hongbin Ji
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

8.  Expression profiles of switch-like genes accurately classify tissue and infectious disease phenotypes in model-based classification.

Authors:  Michael Gormley; Aydin Tozeren
Journal:  BMC Bioinformatics       Date:  2008-11-17       Impact factor: 3.169

9.  Integrin signaling in cancer cell survival and chemoresistance.

Authors:  Fawzi Aoudjit; Kristiina Vuori
Journal:  Chemother Res Pract       Date:  2012-04-11

10.  Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment.

Authors:  Tamasin N Doig; David A Hume; Thanasis Theocharidis; John R Goodlad; Christopher D Gregory; Tom C Freeman
Journal:  BMC Genomics       Date:  2013-07-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.